Pscilly

Reviews of MYCO-001 – Psilocybin from natural fungal sources

No reviews yet. Share the first one.

MYCO-001 – Psilocybin from natural fungal sources by Noveris Health Sciences (formerly Mydecine)

An investigational psilocybin candidate for smoking cessation. A Phase 2/3 trial was planned for Q1 2022; subsequent trial status is not stated. Investigational; not for sale.

Guides about MYCO-001 – Psilocybin from natural fungal sources

Related news

Glossary: Psilocybin

More from Noveris Health Sciences (formerly Mydecine)